Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: A diagnostic validation study

British Journal of General Practice

Volumn 63, Issue 610, 2013, Pages

  Walter, Fiona M ^a   Prevost, A Toby ^c   Vasconcelos, Joana ^f   Hall, Per N ^e   Burrows, Nigel P ^d   Morris, Helen C ^a   Kinmonth, Ann Louise ^b   Emery, Jon D ^f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f NONE

Author keywords

Diagnostic techniques and procedures; General practice; Melanoma; Pigmented skin lesions

Indexed keywords

7 POINT CHECKLIST; ADULT; ARTICLE; CHECKLIST; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTICE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PIGMENT DISORDER; PIGMENTED SKIN LESION; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SKIN PIGMENTATION;

EID: 84877141055     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X667213     Document Type: Article

References (25)

1. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27(36): 6199-6206.
2. Cancer Research UK. http://www.cancerresearchuk.org/home/(accessed 8 Mar 2013).
3. Murchie P, Campbell NC. Pigmented lesions, cutaneous melanoma, and future challenges for primary care. Eur J Gen Pract 2007; 13(3): 151-154.
4. Tsao H, Bevona C, Goggins W, Quinn T. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol 2003; 139(3): 282-288.
5. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282(18): 1737-1744.
6. Mackie RM. An illustrated guide to the recognition of malignant melanoma. Glasgow: Glasgow University Department of Dermatology, 1985.
7. Mackie RM. Malignant melanoma. A guide to early diagnosis. Glasgow: Glasgow University Department of Dermatology, 1989.
8. MacKie RM. Clinical recognition of early invasive malignant melanoma. BMJ 1990; 301(6759): 1005-1006.
9. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer. Clinical guidline 27. London: NICE, 2005. http://publications. nice.org.uk/referral-guidelines-for-suspected-cancer-cg27/ guidance (accessed 8 Mar 2013).
10. Friedman RJ, Rigel D, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. Cancer J Clin 1985; 35(3): 130-151.
11. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004; 292(22): 2771-2776.
12. Liu W, Hill D, Gibbs AF, et al. What features do patients notice that help to distinguish between benign pigmented lesions and melanomas?: the ABCD(E) rule versus the seven-point checklist. Melanoma Res 2005; 15(6): 549-554.
13. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003; 326(7379): 41-44.
14. Walter FM, Morris H, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented skin lesions in primary care: randomsied controlled trial. BMJ 2012; 344: e4110.
15. Marston L, Peacock JL, Yu K, et al. Comparing methods of analysing datasets with small clusters: case studies using four paediatric datasets. Paediatr Perinat Epidemiol 2009; 23(4): 380-392.
16. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148(3): 839-843.
17. Wang W, Davis CS, Soong SJ. Comparison of predictive values of two diagnostic tests from the same sample of subjects using weighted least squares. Stat Med 2006; 25(13): 2215-2229.
18. Keefe M, Dick DC, Wakeel RA. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin Exp Dermatol 1990; 15(3): 167-171.
19. Healsmith MF, Bourke JF, Osborne JE, Graham-Brown RA. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol 1994; 130(1): 48-50.
20. Osborne JE, Bourke JF, Graham-Brown RA, Hutchinson PE. False negative clinical diagnoses of malignant melanoma. Br J Dermatol 1999; 140(5): 902-908.
21. Jackson AM, Morgan DR, Ellison R. Diagnosis of malignant melanoma by general practitioners and hospital specialists. Postgrad Med J 2000; 76(895): 295-298.
22. Thomas L, Tranchand P, Berard F, et al. Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors. Dermatology 1998; 197(1): 11-17.
23. McGovern TW, Litaker MS. Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions. J Dermatol Surg Oncol 1992; 18(1): 22-26.
24. Scope A, Dusza SW, Halpern AC, Rabinovitz H, et al. The 'ugly duckling' sign: agreement between observers. Arch Dermatol 2008; 144(1): 58-64.
25. Sidhu S, Bodger O, Williams N, Roberts DL. The number of benign moles excised for each malignant melanoma: the number needed to treat. Clin Exp Dermatol 2012; 37(1): 6-9.